{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:07:28Z","timestamp":1787069248332,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jaut.2025.103413","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T04:09:00Z","timestamp":1743566940000},"page":"103413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis"],"prefix":"10.1016","volume":"153","author":[{"given":"Marie","family":"Beaufr\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Jacoutot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roula Said","family":"Nahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Hutteau-Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Clavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude Jobart","family":"Malfait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza M.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Breban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9633-2074","authenticated-orcid":false,"given":"Simon","family":"Glatigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2025.103413_bib1","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2025.103413_bib2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0092-8674(90)90512-D","article-title":"Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders","volume":"63","author":"Hammer","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2025.103413_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-065X.1999.tb01317.x","article-title":"Inflammatory disease in HLA-B27 transgenic rats","volume":"169","author":"Taurog","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2025.103413_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101495","article-title":"The microbiome in spondyloarthritis","volume":"33","author":"Breban","year":"2019","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103413_bib5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1084\/jem.178.5.1607","article-title":"Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment","volume":"178","author":"Breban","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2025.103413_bib6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.156.2.794","article-title":"T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats","volume":"156","author":"Breban","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2025.103413_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2025.103413_bib8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2025.103413_bib9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2025.103413_bib10","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar2964","article-title":"Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus","volume":"12","author":"Shah","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2025.103413_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13075-017-1249-5","article-title":"Mechanistic rationales for targeting interleukin-17A in spondyloarthritis","volume":"19","author":"Raychaudhuri","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2025.103413_bib12","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20080159","article-title":"IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition","volume":"205","author":"Kroenke","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2025.103413_bib13","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.4049\/jimmunol.1102515","article-title":"Cutting edge: loss of alpha4 integrin expression differentially affects the homing of Th1 and Th17 cells","volume":"187","author":"Glatigny","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2025.103413_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm1715","article-title":"Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells","volume":"14","author":"Stromnes","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2025.103413_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41584-018-0044-2","article-title":"IL-17 in the immunopathogenesis of spondyloarthritis","volume":"14","author":"Taams","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103413_bib16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/14728222.2021.1973429","article-title":"Axial spondyloarthritis: emerging drug targets","volume":"25","author":"Cherqaoui","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jaut.2025.103413_bib17","article-title":"Innate cells: the alternative source of IL-17 in axial and peripheral spondyloarthritis?","volume":"11","author":"Rosine","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103413_bib18","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/annrheumdis-2019-215356","article-title":"The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies","volume":"78","author":"McGonagle","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103413_bib19","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.33507","article-title":"Enrichment of circulating interleukin-17\u2013secreting interleukin-23 receptor\u2013positive \u03b3\/\u03b4 T cells in patients with active ankylosing spondylitis","volume":"64","author":"Kenna","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2025.103413_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00281-021-00837-0","article-title":"Novel immune cell phenotypes in spondyloarthritis pathogenesis","volume":"43","author":"Mauro","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2025.103413_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-019-0834-9","article-title":"ILC3 in axial spondyloarthritis: the gut angle","volume":"21","author":"Mauro","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2025.103413_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/art.33321","article-title":"Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats","volume":"64","author":"Glatigny","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2025.103413_bib23","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/art.39681","article-title":"Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis: impact of HLA-B27 on mucosal immunity and intestinal microbiota","volume":"68","author":"Asquith","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2025.103413_bib24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/art.38318","article-title":"Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis: reverse IFN signature in SpA APCs","volume":"66","author":"Fert","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2025.103413_bib25","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1084\/jem.178.5.1607","article-title":"Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment","volume":"178","author":"Breban","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2025.103413_bib26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103413_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13075-021-02559-y","article-title":"Effects of a low-dose IL-2 treatment in HLA-B27 transgenic rat model of spondyloarthritis","volume":"23","author":"Araujo","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2025.103413_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1072420","article-title":"Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses","volume":"13","author":"Jouhault","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103413_bib29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells","volume":"10","author":"Duhen","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2025.103413_bib30","first-page":"2249","article-title":"Ex-Th17 (nonclassical Th1) cells are functionally distinct from classical Th1 and Th17 cells and are not constrained by regulatory T cells","volume":"198","author":"Basdeo","year":"2017","journal-title":"J. Inform."},{"key":"10.1016\/j.jaut.2025.103413_bib31","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.20080397","article-title":"Human interleukin 17\u2013producing cells originate from a CD161+CD4+ T cell precursor","volume":"205","author":"Cosmi","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2025.103413_bib32","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.4049\/jimmunol.1203172","article-title":"Cutting edge: the pathogenicity of IFN-gamma-producing Th17 cells is independent of T-bet","volume":"190","author":"Duhen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2025.103413_bib33","article-title":"Imbalance of peripheral lymphocyte subsets in patients with ankylosing spondylitis: a meta-analysis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103413_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-018-1582-3","article-title":"IL-17A induces osteoblast differentiation by activating JAK2\/STAT3 in ankylosing spondylitis","volume":"20","author":"Jo","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2025.103413_bib35","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.39261","article-title":"Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid","volume":"67","author":"Leijten","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2025.103413_bib36","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/art.42627","article-title":"Gut inflammation in axial spondyloarthritis patients is characterized by a marked type 17 skewed mucosal innate\u2010like T cell signature","volume":"75","author":"Mortier","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2025.103413_bib37","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/art.40150","article-title":"Brief report: group 3 innate lymphoid cells in human enthesis","volume":"69","author":"Cuthbert","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2025.103413_bib38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3389\/fimmu.2018.00885","article-title":"Whodunit? The contribution of interleukin (IL)-17\/IL-22-Producing \u03b3\u03b4 T cells, \u03b1\u03b2 T cells, and innate lymphoid cells to the pathogenesis of spondyloarthritis","volume":"9","author":"Reinhardt","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103413_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41467-018-07911-6","article-title":"ROR\u03b3t inhibition selectively targets IL-17 producing iNKT and \u03b3\u03b4-T cells enriched in Spondyloarthritis patients","volume":"10","author":"Venken","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2025.103413_bib40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4049\/jimmunol.170.2.1099","article-title":"CD8\u03b1\u03b2 T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats","volume":"170","author":"May","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2025.103413_bib41","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/art.24599","article-title":"Spondylarthritis in HLA-B27\/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8","volume":"60","author":"Taurog","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2025.103413_bib42","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2019-215210","article-title":"Evidence that tissue resident human enthesis \u03b3\u03b4T-cells can produce IL-17A independently of IL-23R transcript expression","volume":"78","author":"Cuthbert","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103413_bib43","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1038\/s41598-018-25988-3","article-title":"\u03b3\u03b4TCR regulates production of interleukin-27 by neutrophils and attenuates inflammatory arthritis","volume":"8","author":"Bouchareychas","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2025.103413_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20969260","article-title":"Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features?","volume":"12","author":"Clunie","year":"2020","journal-title":"Therapeutic Advances in Musculoskeletal"},{"key":"10.1016\/j.jaut.2025.103413_bib45","article-title":"Both disease activity and HLA\u2010B27 determine gut microbiome dysbiosis in spondyloarthritis","author":"Berland","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2025.103413_bib46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/BOR.0000000000000800","article-title":"Intestinal dysbiosis in spondyloarthritis \u2013 chicken or egg?","volume":"33","author":"Breban","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103413_bib47","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2025.103413_bib48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/cells10020341","article-title":"IL-17A and TNF modulate normal human spinal entheseal bone and soft tissue mesenchymal stem cell osteogenesis, adipogenesis, and stromal function","volume":"10","author":"Russell","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaut.2025.103413_bib49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41584-023-00986-6","article-title":"The bone marrow side of axial spondyloarthritis","volume":"19","author":"Mauro","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103413_bib50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s13075-014-0426-z","article-title":"Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?","volume":"16","author":"Van Baarsen","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2025.103413_bib51","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","article-title":"Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation","volume":"77","author":"Glatt","year":"2018","journal-title":"Ann. Rheum. Dis."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:23:05Z","timestamp":1746152585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841125000587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":51,"alternative-id":["S0896841125000587"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103413","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103413"}}